Safety, Tolerability, Pharmacokinetics, Radiation Dosimetry, and PET Imaging Properties of 89Zr-labeled hNd2 (NMK89) in Patients With Pancreatic Cancer
Clinical trial NCT06129422 · COMPLETED
Trial details
- NCT number
- NCT06129422
- Sponsor
- Nihon Medi-Physics Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-31
- Primary completion
- 2025-10-07
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.